Tim Shaw
Impact in
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Rheumatology 14
- Rheumatoid Arthritis Research and Therapies 13
- Spondyloarthritis Studies and Treatments 2
- Genetics 4
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Paul Emery (2 shared papers)Anna Filipowicz‐Sosnowska (1 shared paper)Randall M. Stevens (1 shared paper)Jacek Szechiński (1 shared paper)Jonathan Edwards (1 shared paper)L Szczepański (1 shared paper)D. Close (1 shared paper)Stanley Cohen (5 shared papers)
- Journals
- Annals of the Rheumatic Diseases (4 papers)Lara D. Veeken (3 papers)RMD Open (1 paper)Expert Opinion on Investigational Drugs (1 paper)Drug Safety (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Tim Shaw
15 papers receiving 2.5k citations
Tim Shaw's Hit Papers
Peers
Comparison fields: 5 of 98
- Rheumatology 1.2k
- Genetics 379
- Immunology 725
- Hematology 318
- Radiology, Nuclear Medicine and Imaging 499
Countries citing papers authored by Tim Shaw
This map shows the geographic impact of Tim Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Shaw more than expected).
Fields of papers citing papers by Tim Shaw
This network shows the impact of papers produced by Tim Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Shaw. The network helps show where Tim Shaw may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis Hit paper breakdown → | 2004 | 2032 |
| 2 | Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis Hit paper breakdown → | 2023 | 133 |
| 3 | 2007 | 116 | |
| 4 | 2011 | 83 | |
| 5 | 2010 | 66 | |
| 6 | 2015 | 36 | |
| 7 | 2021 | 34 | |
| 8 | 2000 | 32 | |
| 9 | 2011 | 18 | |
| 10 | 2021 | 8 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 6 | |
| 13 | A Multidisciplinary Approach to Limb Preservation: The Role of V.A.C. ® Therapy | 2009 | 4 |
| 14 | 2022 | 2 | |
| 15 | 2019 | 1 | |
| 16 | 2019 | 0 |
About Tim Shaw
Tim Shaw is a scholar working on Rheumatology, Genetics, Hematology, Pathology and Forensic Medicine and Surgery, having authored 16 papers that have together received 2.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (13 papers), Chronic Lymphocytic Leukemia Research (4 papers), Spondyloarthritis Studies and Treatments (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Blood Coagulation and Thrombosis Mechanisms (1 paper), Protease and Inhibitor Mechanisms (1 paper) and Surgical site infection prevention (1 paper). The work is most often cited by research in Rheumatology (1.2k citations), Genetics (379 citations), Immunology (725 citations), Hematology (318 citations) and Radiology, Nuclear Medicine and Imaging (499 citations). Tim Shaw has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Paul Emery, Anna Filipowicz‐Sosnowska, Randall M. Stevens, Jacek Szechiński, Jonathan Edwards, L Szczepański, D. Close, Stanley Cohen, Charles Peterfy and Song Ren. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, Expert Opinion on Investigational Drugs and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.